Pandemic policies seem to have overlooked the key workers who keep the global trade system afloat: merchant seamen. More than a quarter of a million are at sea unwillingly. Misinformation was a plague even before covid-19. Now it’s a matter of life and death—and of political persuasion. And why pedigree puppies are so pricey in Britain. For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer
In which the discoverer of neutron stars is largely ignored for her achievement, and John wonders about the precise verbiage to summon "Beetlejuice." Certificate #52246.
iRobot is the only robot company that’s WFH right now, but we’ve got a bold idea for its next move: Sell yourself. Shopify shares surged on word it is partnering with Walmart for an unprecedented rebel alliance against the Amazon empire. And Airbnb just whipped up “Project Lighthouse” to fix racism on its platform — We think the entire gig economy could use that.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
On Monday, the conservative Supreme Court extended civil rights protections to transgender and gay Americans. The ruling is not controversial -- supermajorities of polled citizens say discrimination against LGBTQ people should be illegal. But Monday’s decision comes ahead of a flurry of rulings on other closely-watched cases involving the president’s financial records, the DACA program, abortion rights, and more. Does this win for the left clear a path for the court to hand down some bitter pills in the next few weeks?
Does getting the coronavirus once make you immune to it or could you get it again? Many are looking to antibody tests for answers. The logic is: if I have antibodies for the coronavirus, I must be immune.
Well, turns out ... it's complicated, as Katherine Wu writes for the Smithsonian Magazine. We invited her onto the show to explain.
Between episodes, you can catch up with Maddie on Twitter @maddie_sofia. Plus, we always want to hear what's on your mind — coronavirus or otherwise. Tell us by emailing shortwave@npr.org.
What’s the key to unlocking your team’s potential? Jeff Weiner, longtime CEO of LinkedIn, shares key steps leaders can take to get the most out of a diverse team.
Yesterday the Supreme Court ruled that the Civil Rights Act protects LGBTQ+ employees from workplace discrimination in a 6-3 ruling. This is the first major case involving transgender rights, and it comes from a decidedly conservative court. We get into what it means, and how we got here.
Plus, the latest on coronavirus, where cases are on the rise and how states and business are reacting.
And in headlines: BLM protestor Oluwatoyin Salau found dead in Florida, hummingbirds see secret colors, and Christopher Nolan’s ‘Tenet’ delayed at movie theaters.
Akilah & Gideon’s book recommendations:
Obviously: Stories From My Timeline by Akilah Hughes
Nine years ago, Dennis Lunev moved from Russia to the USA. He likes to polish his skills in archery and throw axes. Previously, he was a software engineer attempting to build SaaS solutions that didn’t quite pan out. Afterwards while doing integration consulting he saw the need to connect payment gateways to HubSpot, so he set out to build DepositFix – a way to directly integrate Stripe and PayPal into the world’s most used CRM.
Kim Holmes, author of “The Closing of the Liberal Mind” and executive vice president at The Heritage Foundation, joins The Daily Signal Podcast to discuss the resignation of New York Times opinion editor James Bennet after he ran an op-ed by Sen. Tom Cotton, and the outraged reaction to J.K. Rowling’s essay on gender identity. Holmes also outlines the intellectual roots of the current speech and thought policing and why the left has become so close-minded.
We also cover these stories:
The Supreme Court issues a major decision on discrimination and LGBT employees.
Justices Thomas and Kavanaugh criticize their Supreme Court colleagues for not taking up a Second Amendment case.
The Food and Drug administration takes action on anti-malaria drug explored as a possible treatment for COVID-19.
